nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—Methamphetamine—obesity	0.277	1	CrCtD
Nateglinide—type 2 diabetes mellitus—obesity	0.247	1	CtDrD
Nateglinide—PPARG—obesity	0.0606	0.727	CbGaD
Nateglinide—ORM1—Bupropion—obesity	0.0246	0.223	CbGbCtD
Nateglinide—ALB—obesity	0.0228	0.273	CbGaD
Nateglinide—Lacosamide—Phentermine—obesity	0.0132	0.065	CrCrCtD
Nateglinide—Lacosamide—Methamphetamine—obesity	0.0118	0.0579	CrCrCtD
Nateglinide—Aspartame—Methamphetamine—obesity	0.0118	0.0579	CrCrCtD
Nateglinide—Dextroamphetamine—Diethylpropion—obesity	0.0105	0.0518	CrCrCtD
Nateglinide—Amphetamine—Diethylpropion—obesity	0.0105	0.0518	CrCrCtD
Nateglinide—Methamphetamine—Diethylpropion—obesity	0.0102	0.0503	CrCrCtD
Nateglinide—Dextroamphetamine—Phenylpropanolamine—obesity	0.0102	0.0503	CrCrCtD
Nateglinide—Amphetamine—Phenylpropanolamine—obesity	0.0102	0.0503	CrCrCtD
Nateglinide—Methamphetamine—Phenylpropanolamine—obesity	0.00994	0.0489	CrCrCtD
Nateglinide—Phenacemide—Phentermine—obesity	0.00897	0.0441	CrCrCtD
Nateglinide—SLC22A6—Cimetidine—obesity	0.00892	0.0808	CbGbCtD
Nateglinide—Amphetamine—Phentermine—obesity	0.0087	0.0428	CrCrCtD
Nateglinide—Dextroamphetamine—Phentermine—obesity	0.0087	0.0428	CrCrCtD
Nateglinide—Methamphetamine—Phentermine—obesity	0.00845	0.0415	CrCrCtD
Nateglinide—CYP3A7—Cimetidine—obesity	0.00814	0.0737	CbGbCtD
Nateglinide—CYP3A7-CYP3A51P—Cimetidine—obesity	0.00814	0.0737	CbGbCtD
Nateglinide—L-Phenylalanine—Diethylpropion—obesity	0.00802	0.0394	CrCrCtD
Nateglinide—Phenacemide—Methamphetamine—obesity	0.00799	0.0393	CrCrCtD
Nateglinide—L-Phenylalanine—Phenylpropanolamine—obesity	0.00778	0.0383	CrCrCtD
Nateglinide—Amphetamine—Methamphetamine—obesity	0.00775	0.0381	CrCrCtD
Nateglinide—Dextroamphetamine—Methamphetamine—obesity	0.00775	0.0381	CrCrCtD
Nateglinide—L-Phenylalanine—Phentermine—obesity	0.00662	0.0325	CrCrCtD
Nateglinide—CYP2C9—Phentermine—obesity	0.00656	0.0594	CbGbCtD
Nateglinide—Dextroamphetamine—Benzphetamine—obesity	0.00615	0.0302	CrCrCtD
Nateglinide—Amphetamine—Benzphetamine—obesity	0.00615	0.0302	CrCrCtD
Nateglinide—CYP3A5—Cimetidine—obesity	0.0061	0.0553	CbGbCtD
Nateglinide—CYP2D6—Phentermine—obesity	0.006	0.0543	CbGbCtD
Nateglinide—Methamphetamine—Benzphetamine—obesity	0.00597	0.0294	CrCrCtD
Nateglinide—L-Phenylalanine—Methamphetamine—obesity	0.0059	0.029	CrCrCtD
Nateglinide—CYP2C9—Bupropion—obesity	0.00558	0.0505	CbGbCtD
Nateglinide—CYP2D6—Bupropion—obesity	0.0051	0.0462	CbGbCtD
Nateglinide—CYP3A4—Sibutramine—obesity	0.00503	0.0456	CbGbCtD
Nateglinide—CYP2D6—Methamphetamine—obesity	0.00479	0.0434	CbGbCtD
Nateglinide—CYP2C9—Cimetidine—obesity	0.00409	0.0371	CbGbCtD
Nateglinide—CYP3A4—Benzphetamine—obesity	0.00381	0.0345	CbGbCtD
Nateglinide—CYP2D6—Cimetidine—obesity	0.00374	0.0339	CbGbCtD
Nateglinide—CYP3A4—Bupropion—obesity	0.00324	0.0294	CbGbCtD
Nateglinide—CYP3A4—Orlistat—obesity	0.00264	0.0239	CbGbCtD
Nateglinide—CYP3A4—Cimetidine—obesity	0.00238	0.0216	CbGbCtD
Nateglinide—CYP3A4—Topiramate—obesity	0.00156	0.0141	CbGbCtD
Nateglinide—ORM1—bile—obesity	0.00128	0.108	CbGeAlD
Nateglinide—PPARG—brown adipose tissue—obesity	0.00103	0.0865	CbGeAlD
Nateglinide—Urine output increased—Diethylpropion—obesity	0.000472	0.0158	CcSEcCtD
Nateglinide—Gastrointestinal symptom NOS—Orlistat—obesity	0.000466	0.0156	CcSEcCtD
Nateglinide—Sweating—Benzphetamine—obesity	0.000432	0.0144	CcSEcCtD
Nateglinide—Polyuria—Diethylpropion—obesity	0.000431	0.0144	CcSEcCtD
Nateglinide—Sweating—Phendimetrazine—obesity	0.000393	0.0132	CcSEcCtD
Nateglinide—ORM1—gall bladder—obesity	0.000357	0.0299	CbGeAlD
Nateglinide—Tremor—Methamphetamine—obesity	0.000342	0.0114	CcSEcCtD
Nateglinide—Tremor—Benzphetamine—obesity	0.00033	0.011	CcSEcCtD
Nateglinide—Palpitations—Methamphetamine—obesity	0.000322	0.0108	CcSEcCtD
Nateglinide—Sweating increased—Diethylpropion—obesity	0.000319	0.0107	CcSEcCtD
Nateglinide—ALB—gall bladder—obesity	0.000313	0.0262	CbGeAlD
Nateglinide—Palpitations—Benzphetamine—obesity	0.000311	0.0104	CcSEcCtD
Nateglinide—KCNJ11—islet of Langerhans—obesity	0.000311	0.026	CbGeAlD
Nateglinide—Arthropathy—Orlistat—obesity	0.000301	0.0101	CcSEcCtD
Nateglinide—Tremor—Phendimetrazine—obesity	0.0003	0.0101	CcSEcCtD
Nateglinide—Arthropathy—Sibutramine—obesity	0.000292	0.00976	CcSEcCtD
Nateglinide—ABCC8—islet of Langerhans—obesity	0.000286	0.024	CbGeAlD
Nateglinide—Palpitations—Phendimetrazine—obesity	0.000283	0.00949	CcSEcCtD
Nateglinide—Hyperhidrosis—Benzphetamine—obesity	0.000278	0.00929	CcSEcCtD
Nateglinide—UGT1A9—digestive system—obesity	0.000267	0.0224	CbGeAlD
Nateglinide—Dyspepsia—Methamphetamine—obesity	0.000262	0.00877	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Methamphetamine—obesity	0.000257	0.00861	CcSEcCtD
Nateglinide—Tremor—Phenylpropanolamine—obesity	0.000257	0.00859	CcSEcCtD
Nateglinide—Hyperhidrosis—Phendimetrazine—obesity	0.000253	0.00847	CcSEcCtD
Nateglinide—Dyspepsia—Benzphetamine—obesity	0.000253	0.00846	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Benzphetamine—obesity	0.000248	0.0083	CcSEcCtD
Nateglinide—Urine output increased—Orlistat—obesity	0.000248	0.00829	CcSEcCtD
Nateglinide—Tremor—Phentermine—obesity	0.000246	0.00822	CcSEcCtD
Nateglinide—Hepatic enzyme increased—Bupropion—obesity	0.000244	0.00818	CcSEcCtD
Nateglinide—Urticaria—Methamphetamine—obesity	0.000237	0.00792	CcSEcCtD
Nateglinide—Erythema multiforme—Cimetidine—obesity	0.000236	0.00789	CcSEcCtD
Nateglinide—Palpitations—Phentermine—obesity	0.000232	0.00775	CcSEcCtD
Nateglinide—Urticaria—Benzphetamine—obesity	0.000228	0.00764	CcSEcCtD
Nateglinide—Polyuria—Orlistat—obesity	0.000227	0.00758	CcSEcCtD
Nateglinide—Trandolapril—CES1—obesity	0.000226	0.164	CrCbGaD
Nateglinide—KCNJ11—cardiovascular system—obesity	0.000225	0.0188	CbGeAlD
Nateglinide—UGT1A9—endocrine gland—obesity	0.00022	0.0185	CbGeAlD
Nateglinide—Hypersensitivity—Methamphetamine—obesity	0.000219	0.00734	CcSEcCtD
Nateglinide—PPARG—islet of Langerhans—obesity	0.000219	0.0183	CbGeAlD
Nateglinide—Lacosamide—CA3—obesity	0.000215	0.156	CrCbGaD
Nateglinide—Tremor—Diethylpropion—obesity	0.000214	0.00715	CcSEcCtD
Nateglinide—Increased appetite—Orlistat—obesity	0.000212	0.00709	CcSEcCtD
Nateglinide—Hypersensitivity—Benzphetamine—obesity	0.000212	0.00708	CcSEcCtD
Nateglinide—Injury—Sibutramine—obesity	0.000209	0.00701	CcSEcCtD
Nateglinide—Urine output increased—Bupropion—obesity	0.000209	0.007	CcSEcCtD
Nateglinide—Thirst—Orlistat—obesity	0.000209	0.007	CcSEcCtD
Nateglinide—ABCC8—cardiovascular system—obesity	0.000207	0.0174	CbGeAlD
Nateglinide—Amphetamine—CARTPT—obesity	0.000207	0.15	CrCbGaD
Nateglinide—Abdominal pain—Phendimetrazine—obesity	0.000207	0.00693	CcSEcCtD
Nateglinide—PPARG—respiratory system—obesity	0.000206	0.0173	CbGeAlD
Nateglinide—Increased appetite—Sibutramine—obesity	0.000205	0.00686	CcSEcCtD
Nateglinide—Hypoglycaemia—Orlistat—obesity	0.000204	0.00682	CcSEcCtD
Nateglinide—Diarrhoea—Methamphetamine—obesity	0.000204	0.00682	CcSEcCtD
Nateglinide—Thirst—Sibutramine—obesity	0.000202	0.00677	CcSEcCtD
Nateglinide—Palpitations—Diethylpropion—obesity	0.000202	0.00675	CcSEcCtD
Nateglinide—Osteoarthritis—Orlistat—obesity	0.000199	0.00666	CcSEcCtD
Nateglinide—UGT1A9—liver—obesity	0.000199	0.0167	CbGeAlD
Nateglinide—Hypoglycaemia—Sibutramine—obesity	0.000197	0.0066	CcSEcCtD
Nateglinide—Dizziness—Methamphetamine—obesity	0.000197	0.00659	CcSEcCtD
Nateglinide—Diarrhoea—Benzphetamine—obesity	0.000196	0.00658	CcSEcCtD
Nateglinide—Osteoarthritis—Sibutramine—obesity	0.000193	0.00644	CcSEcCtD
Nateglinide—Polyuria—Bupropion—obesity	0.000191	0.0064	CcSEcCtD
Nateglinide—Dizziness—Benzphetamine—obesity	0.00019	0.00636	CcSEcCtD
Nateglinide—SLC16A1—cardiovascular system—obesity	0.000188	0.0158	CbGeAlD
Nateglinide—Dyspepsia—Phentermine—obesity	0.000188	0.0063	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Phentermine—obesity	0.000185	0.00618	CcSEcCtD
Nateglinide—Fatigue—Phentermine—obesity	0.000184	0.00617	CcSEcCtD
Nateglinide—ABCC8—pituitary gland—obesity	0.000183	0.0154	CbGeAlD
Nateglinide—CYP3A7—endocrine gland—obesity	0.000183	0.0154	CbGeAlD
Nateglinide—Injury—Bupropion—obesity	0.000183	0.00611	CcSEcCtD
Nateglinide—Hyperhidrosis—Diethylpropion—obesity	0.00018	0.00602	CcSEcCtD
Nateglinide—Diarrhoea—Phendimetrazine—obesity	0.000179	0.00599	CcSEcCtD
Nateglinide—Increased appetite—Bupropion—obesity	0.000179	0.00598	CcSEcCtD
Nateglinide—KCNJ11—adrenal gland—obesity	0.000178	0.0149	CbGeAlD
Nateglinide—Thirst—Bupropion—obesity	0.000176	0.0059	CcSEcCtD
Nateglinide—Dizziness—Phendimetrazine—obesity	0.000173	0.00579	CcSEcCtD
Nateglinide—Hypoglycaemia—Bupropion—obesity	0.000172	0.00576	CcSEcCtD
Nateglinide—Influenza—Orlistat—obesity	0.000172	0.00575	CcSEcCtD
Nateglinide—Nausea—Benzphetamine—obesity	0.000171	0.00571	CcSEcCtD
Nateglinide—Urticaria—Phentermine—obesity	0.00017	0.00569	CcSEcCtD
Nateglinide—Aspartame—TRPV1—obesity	0.000169	0.123	CrCbGaD
Nateglinide—Abdominal pain—Phentermine—obesity	0.000169	0.00566	CcSEcCtD
Nateglinide—Osteoarthritis—Bupropion—obesity	0.000168	0.00562	CcSEcCtD
Nateglinide—Sweating increased—Orlistat—obesity	0.000167	0.00561	CcSEcCtD
Nateglinide—SLC16A1—pituitary gland—obesity	0.000167	0.014	CbGeAlD
Nateglinide—Influenza—Sibutramine—obesity	0.000166	0.00557	CcSEcCtD
Nateglinide—SLC16A1—adipose tissue—obesity	0.000166	0.0139	CbGeAlD
Nateglinide—CYP3A7—liver—obesity	0.000165	0.0138	CbGeAlD
Nateglinide—Hypersensitivity—Phenylpropanolamine—obesity	0.000165	0.00551	CcSEcCtD
Nateglinide—SLC15A1—digestive system—obesity	0.000164	0.0138	CbGeAlD
Nateglinide—Dyspepsia—Diethylpropion—obesity	0.000164	0.00548	CcSEcCtD
Nateglinide—ABCC8—adrenal gland—obesity	0.000164	0.0137	CbGeAlD
Nateglinide—Arthropathy—Topiramate—obesity	0.000162	0.00542	CcSEcCtD
Nateglinide—SLC15A2—respiratory system—obesity	0.000162	0.0135	CbGeAlD
Nateglinide—Gastrointestinal disorder—Diethylpropion—obesity	0.000161	0.00538	CcSEcCtD
Nateglinide—Bronchitis—Sibutramine—obesity	0.00016	0.00536	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Orlistat—obesity	0.00016	0.00535	CcSEcCtD
Nateglinide—PPARG—cardiovascular system—obesity	0.000158	0.0132	CbGeAlD
Nateglinide—SLC16A1—digestive system—obesity	0.000156	0.0131	CbGeAlD
Nateglinide—Hepatic enzyme increased—Topiramate—obesity	0.000156	0.00521	CcSEcCtD
Nateglinide—Nausea—Phendimetrazine—obesity	0.000155	0.0052	CcSEcCtD
Nateglinide—KCNJ11—endocrine gland—obesity	0.000154	0.0129	CbGeAlD
Nateglinide—Asthenia—Phentermine—obesity	0.000153	0.00514	CcSEcCtD
Nateglinide—Fatigue—Cimetidine—obesity	0.000153	0.00511	CcSEcCtD
Nateglinide—Neuropathy peripheral—Orlistat—obesity	0.00015	0.00503	CcSEcCtD
Nateglinide—SLC16A1—adrenal gland—obesity	0.000149	0.0125	CbGeAlD
Nateglinide—CYP2D6—hindbrain—obesity	0.000148	0.0124	CbGeAlD
Nateglinide—Urticaria—Diethylpropion—obesity	0.000148	0.00495	CcSEcCtD
Nateglinide—Dizziness—Phenylpropanolamine—obesity	0.000148	0.00495	CcSEcCtD
Nateglinide—Diarrhoea—Phentermine—obesity	0.000146	0.0049	CcSEcCtD
Nateglinide—Neuropathy peripheral—Sibutramine—obesity	0.000145	0.00487	CcSEcCtD
Nateglinide—Influenza—Bupropion—obesity	0.000145	0.00486	CcSEcCtD
Nateglinide—Hepatobiliary disease—Orlistat—obesity	0.000145	0.00485	CcSEcCtD
Nateglinide—Sweating—Sibutramine—obesity	0.000142	0.00476	CcSEcCtD
Nateglinide—Vomiting—Phenylpropanolamine—obesity	0.000142	0.00476	CcSEcCtD
Nateglinide—ABCC8—endocrine gland—obesity	0.000142	0.0119	CbGeAlD
Nateglinide—Dizziness—Phentermine—obesity	0.000141	0.00474	CcSEcCtD
Nateglinide—Sweating increased—Bupropion—obesity	0.000141	0.00473	CcSEcCtD
Nateglinide—Rash—Phenylpropanolamine—obesity	0.000141	0.00472	CcSEcCtD
Nateglinide—Dermatitis—Phenylpropanolamine—obesity	0.000141	0.00471	CcSEcCtD
Nateglinide—CYP3A7-CYP3A51P—liver—obesity	0.000141	0.0118	CbGeAlD
Nateglinide—Bronchitis—Bupropion—obesity	0.000139	0.00467	CcSEcCtD
Nateglinide—PPARG—adipose tissue—obesity	0.000139	0.0117	CbGeAlD
Nateglinide—Vomiting—Phentermine—obesity	0.000136	0.00455	CcSEcCtD
Nateglinide—SLC15A1—endocrine gland—obesity	0.000136	0.0114	CbGeAlD
Nateglinide—Oedema peripheral—Orlistat—obesity	0.000136	0.00454	CcSEcCtD
Nateglinide—Rash—Phentermine—obesity	0.000135	0.00452	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Bupropion—obesity	0.000135	0.00451	CcSEcCtD
Nateglinide—Dermatitis—Phentermine—obesity	0.000135	0.00451	CcSEcCtD
Nateglinide—Urine output increased—Topiramate—obesity	0.000133	0.00446	CcSEcCtD
Nateglinide—Nausea—Phenylpropanolamine—obesity	0.000133	0.00445	CcSEcCtD
Nateglinide—PPARG—digestive system—obesity	0.000131	0.011	CbGeAlD
Nateglinide—Oedema peripheral—Sibutramine—obesity	0.000131	0.00439	CcSEcCtD
Nateglinide—Hypersensitivity—Cimetidine—obesity	0.00013	0.00437	CcSEcCtD
Nateglinide—CYP3A5—islet of Langerhans—obesity	0.00013	0.0109	CbGeAlD
Nateglinide—SLC16A1—endocrine gland—obesity	0.000129	0.0108	CbGeAlD
Nateglinide—Diarrhoea—Diethylpropion—obesity	0.000127	0.00426	CcSEcCtD
Nateglinide—Nausea—Phentermine—obesity	0.000127	0.00425	CcSEcCtD
Nateglinide—Asthenia—Cimetidine—obesity	0.000127	0.00425	CcSEcCtD
Nateglinide—Neuropathy peripheral—Bupropion—obesity	0.000127	0.00424	CcSEcCtD
Nateglinide—ABCC4—adipose tissue—obesity	0.000127	0.0106	CbGeAlD
Nateglinide—Jaundice—Bupropion—obesity	0.000126	0.00422	CcSEcCtD
Nateglinide—PPARG—adrenal gland—obesity	0.000125	0.0105	CbGeAlD
Nateglinide—Immune system disorder—Orlistat—obesity	0.000124	0.00416	CcSEcCtD
Nateglinide—Sweating—Bupropion—obesity	0.000124	0.00415	CcSEcCtD
Nateglinide—Dizziness—Diethylpropion—obesity	0.000123	0.00412	CcSEcCtD
Nateglinide—CYP3A5—respiratory system—obesity	0.000123	0.0103	CbGeAlD
Nateglinide—SLC15A1—liver—obesity	0.000122	0.0103	CbGeAlD
Nateglinide—Polyuria—Topiramate—obesity	0.000122	0.00408	CcSEcCtD
Nateglinide—Diarrhoea—Cimetidine—obesity	0.000121	0.00406	CcSEcCtD
Nateglinide—Immune system disorder—Sibutramine—obesity	0.00012	0.00403	CcSEcCtD
Nateglinide—Malnutrition—Orlistat—obesity	0.00012	0.00401	CcSEcCtD
Nateglinide—ABCC4—digestive system—obesity	0.000119	0.00998	CbGeAlD
Nateglinide—Vomiting—Diethylpropion—obesity	0.000118	0.00396	CcSEcCtD
Nateglinide—Rash—Diethylpropion—obesity	0.000117	0.00393	CcSEcCtD
Nateglinide—ALB—adrenal gland—obesity	0.000117	0.00983	CbGeAlD
Nateglinide—Dermatitis—Diethylpropion—obesity	0.000117	0.00392	CcSEcCtD
Nateglinide—Dizziness—Cimetidine—obesity	0.000117	0.00392	CcSEcCtD
Nateglinide—SLC16A1—liver—obesity	0.000117	0.00976	CbGeAlD
Nateglinide—ORM1—endocrine gland—obesity	0.000116	0.00972	CbGeAlD
Nateglinide—Malnutrition—Sibutramine—obesity	0.000116	0.00388	CcSEcCtD
Nateglinide—Back pain—Orlistat—obesity	0.000116	0.00388	CcSEcCtD
Nateglinide—Oedema peripheral—Bupropion—obesity	0.000114	0.00383	CcSEcCtD
Nateglinide—Increased appetite—Topiramate—obesity	0.000114	0.00381	CcSEcCtD
Nateglinide—ABCC4—adrenal gland—obesity	0.000114	0.00951	CbGeAlD
Nateglinide—Vomiting—Cimetidine—obesity	0.000113	0.00377	CcSEcCtD
Nateglinide—Thirst—Topiramate—obesity	0.000112	0.00376	CcSEcCtD
Nateglinide—Back pain—Sibutramine—obesity	0.000112	0.00375	CcSEcCtD
Nateglinide—Rash—Cimetidine—obesity	0.000112	0.00374	CcSEcCtD
Nateglinide—Dermatitis—Cimetidine—obesity	0.000112	0.00373	CcSEcCtD
Nateglinide—Nausea—Diethylpropion—obesity	0.000111	0.0037	CcSEcCtD
Nateglinide—PTGS1—respiratory system—obesity	0.00011	0.00924	CbGeAlD
Nateglinide—Erythema multiforme—Bupropion—obesity	0.00011	0.00367	CcSEcCtD
Nateglinide—SLC15A2—pituitary gland—obesity	0.00011	0.00918	CbGeAlD
Nateglinide—Hypoglycaemia—Topiramate—obesity	0.00011	0.00367	CcSEcCtD
Nateglinide—Tremor—Sibutramine—obesity	0.000109	0.00364	CcSEcCtD
Nateglinide—PPARG—endocrine gland—obesity	0.000108	0.00908	CbGeAlD
Nateglinide—Osteoarthritis—Topiramate—obesity	0.000107	0.00358	CcSEcCtD
Nateglinide—Palpitations—Orlistat—obesity	0.000106	0.00354	CcSEcCtD
Nateglinide—Nausea—Cimetidine—obesity	0.000105	0.00352	CcSEcCtD
Nateglinide—Immune system disorder—Bupropion—obesity	0.000105	0.00351	CcSEcCtD
Nateglinide—ORM1—liver—obesity	0.000105	0.00876	CbGeAlD
Nateglinide—Cough—Orlistat—obesity	0.000105	0.0035	CcSEcCtD
Nateglinide—Palpitations—Sibutramine—obesity	0.000102	0.00343	CcSEcCtD
Nateglinide—Cough—Sibutramine—obesity	0.000101	0.00339	CcSEcCtD
Nateglinide—Malnutrition—Bupropion—obesity	0.000101	0.00338	CcSEcCtD
Nateglinide—ABCC4—endocrine gland—obesity	9.84e-05	0.00825	CbGeAlD
Nateglinide—SLC15A2—adrenal gland—obesity	9.79e-05	0.0082	CbGeAlD
Nateglinide—Back pain—Bupropion—obesity	9.78e-05	0.00327	CcSEcCtD
Nateglinide—PPARG—liver—obesity	9.78e-05	0.00819	CbGeAlD
Nateglinide—Tremor—Bupropion—obesity	9.47e-05	0.00317	CcSEcCtD
Nateglinide—Hyperhidrosis—Orlistat—obesity	9.45e-05	0.00316	CcSEcCtD
Nateglinide—CYP2C9—cardiovascular system—obesity	9.26e-05	0.00776	CbGeAlD
Nateglinide—ALB—liver—obesity	9.17e-05	0.00768	CbGeAlD
Nateglinide—Hyperhidrosis—Sibutramine—obesity	9.15e-05	0.00306	CcSEcCtD
Nateglinide—Sweating increased—Topiramate—obesity	9e-05	0.00301	CcSEcCtD
Nateglinide—Palpitations—Bupropion—obesity	8.93e-05	0.00299	CcSEcCtD
Nateglinide—Bronchitis—Topiramate—obesity	8.89e-05	0.00297	CcSEcCtD
Nateglinide—ABCC4—liver—obesity	8.88e-05	0.00744	CbGeAlD
Nateglinide—Cough—Bupropion—obesity	8.82e-05	0.00295	CcSEcCtD
Nateglinide—Dyspepsia—Orlistat—obesity	8.61e-05	0.00288	CcSEcCtD
Nateglinide—Upper respiratory tract infection—Topiramate—obesity	8.59e-05	0.00288	CcSEcCtD
Nateglinide—SLC15A2—endocrine gland—obesity	8.49e-05	0.00711	CbGeAlD
Nateglinide—PTGS1—cardiovascular system—obesity	8.45e-05	0.00708	CbGeAlD
Nateglinide—Gastrointestinal disorder—Orlistat—obesity	8.44e-05	0.00283	CcSEcCtD
Nateglinide—Fatigue—Orlistat—obesity	8.43e-05	0.00282	CcSEcCtD
Nateglinide—Dyspepsia—Sibutramine—obesity	8.33e-05	0.00279	CcSEcCtD
Nateglinide—CYP3A5—adipose tissue—obesity	8.29e-05	0.00695	CbGeAlD
Nateglinide—Gastrointestinal disorder—Sibutramine—obesity	8.17e-05	0.00273	CcSEcCtD
Nateglinide—Neuropathy peripheral—Topiramate—obesity	8.08e-05	0.0027	CcSEcCtD
Nateglinide—Gastrointestinal pain—Orlistat—obesity	7.99e-05	0.00268	CcSEcCtD
Nateglinide—Hyperhidrosis—Bupropion—obesity	7.97e-05	0.00267	CcSEcCtD
Nateglinide—CYP3A5—digestive system—obesity	7.81e-05	0.00654	CbGeAlD
Nateglinide—Urticaria—Orlistat—obesity	7.77e-05	0.0026	CcSEcCtD
Nateglinide—Gastrointestinal pain—Sibutramine—obesity	7.74e-05	0.00259	CcSEcCtD
Nateglinide—Abdominal pain—Orlistat—obesity	7.73e-05	0.00259	CcSEcCtD
Nateglinide—CYP2C9—digestive system—obesity	7.68e-05	0.00644	CbGeAlD
Nateglinide—Urticaria—Sibutramine—obesity	7.52e-05	0.00252	CcSEcCtD
Nateglinide—PTGS1—pituitary gland—obesity	7.48e-05	0.00627	CbGeAlD
Nateglinide—Abdominal pain—Sibutramine—obesity	7.48e-05	0.0025	CcSEcCtD
Nateglinide—PTGS1—adipose tissue—obesity	7.45e-05	0.00624	CbGeAlD
Nateglinide—Oedema peripheral—Topiramate—obesity	7.29e-05	0.00244	CcSEcCtD
Nateglinide—Dyspepsia—Bupropion—obesity	7.26e-05	0.00243	CcSEcCtD
Nateglinide—Hypersensitivity—Orlistat—obesity	7.2e-05	0.00241	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Bupropion—obesity	7.12e-05	0.00238	CcSEcCtD
Nateglinide—Fatigue—Bupropion—obesity	7.11e-05	0.00238	CcSEcCtD
Nateglinide—Spirapril—ACE—obesity	7.11e-05	0.0515	CrCbGaD
Nateglinide—PTGS1—digestive system—obesity	7.01e-05	0.00588	CbGeAlD
Nateglinide—Asthenia—Orlistat—obesity	7.01e-05	0.00235	CcSEcCtD
Nateglinide—Erythema multiforme—Topiramate—obesity	6.99e-05	0.00234	CcSEcCtD
Nateglinide—Hypersensitivity—Sibutramine—obesity	6.97e-05	0.00233	CcSEcCtD
Nateglinide—Pruritus—Orlistat—obesity	6.92e-05	0.00232	CcSEcCtD
Nateglinide—Mitiglinide—PPARG—obesity	6.79e-05	0.0492	CrCbGaD
Nateglinide—Asthenia—Sibutramine—obesity	6.79e-05	0.00227	CcSEcCtD
Nateglinide—Gastrointestinal pain—Bupropion—obesity	6.74e-05	0.00226	CcSEcCtD
Nateglinide—Pruritus—Sibutramine—obesity	6.69e-05	0.00224	CcSEcCtD
Nateglinide—Diarrhoea—Orlistat—obesity	6.69e-05	0.00224	CcSEcCtD
Nateglinide—PTGS1—adrenal gland—obesity	6.68e-05	0.0056	CbGeAlD
Nateglinide—Immune system disorder—Topiramate—obesity	6.68e-05	0.00224	CcSEcCtD
Nateglinide—Urticaria—Bupropion—obesity	6.55e-05	0.00219	CcSEcCtD
Nateglinide—Abdominal pain—Bupropion—obesity	6.52e-05	0.00218	CcSEcCtD
Nateglinide—Diarrhoea—Sibutramine—obesity	6.47e-05	0.00217	CcSEcCtD
Nateglinide—Dizziness—Orlistat—obesity	6.46e-05	0.00216	CcSEcCtD
Nateglinide—CYP3A5—endocrine gland—obesity	6.45e-05	0.00541	CbGeAlD
Nateglinide—Malnutrition—Topiramate—obesity	6.44e-05	0.00216	CcSEcCtD
Nateglinide—CYP2C9—endocrine gland—obesity	6.35e-05	0.00532	CbGeAlD
Nateglinide—Cilazapril—ACE—obesity	6.34e-05	0.0459	CrCbGaD
Nateglinide—Lisinopril—ACE—obesity	6.34e-05	0.0459	CrCbGaD
Nateglinide—Dizziness—Sibutramine—obesity	6.26e-05	0.00209	CcSEcCtD
Nateglinide—Back pain—Topiramate—obesity	6.23e-05	0.00208	CcSEcCtD
Nateglinide—Vomiting—Orlistat—obesity	6.22e-05	0.00208	CcSEcCtD
Nateglinide—Rash—Orlistat—obesity	6.16e-05	0.00206	CcSEcCtD
Nateglinide—Dermatitis—Orlistat—obesity	6.16e-05	0.00206	CcSEcCtD
Nateglinide—Trandolapril—ACE—obesity	6.14e-05	0.0444	CrCbGaD
Nateglinide—Ramipril—ACE—obesity	6.14e-05	0.0444	CrCbGaD
Nateglinide—Ramipril—BCHE—obesity	6.12e-05	0.0443	CrCbGaD
Nateglinide—Hypersensitivity—Bupropion—obesity	6.08e-05	0.00203	CcSEcCtD
Nateglinide—Tremor—Topiramate—obesity	6.03e-05	0.00202	CcSEcCtD
Nateglinide—Vomiting—Sibutramine—obesity	6.02e-05	0.00201	CcSEcCtD
Nateglinide—Rash—Sibutramine—obesity	5.97e-05	0.002	CcSEcCtD
Nateglinide—Dermatitis—Sibutramine—obesity	5.96e-05	0.002	CcSEcCtD
Nateglinide—Asthenia—Bupropion—obesity	5.92e-05	0.00198	CcSEcCtD
Nateglinide—CYP3A4—digestive system—obesity	5.86e-05	0.00491	CbGeAlD
Nateglinide—Pruritus—Bupropion—obesity	5.84e-05	0.00195	CcSEcCtD
Nateglinide—CYP3A5—liver—obesity	5.82e-05	0.00487	CbGeAlD
Nateglinide—Nausea—Orlistat—obesity	5.81e-05	0.00194	CcSEcCtD
Nateglinide—PTGS1—endocrine gland—obesity	5.8e-05	0.00486	CbGeAlD
Nateglinide—CYP2D6—digestive system—obesity	5.77e-05	0.00483	CbGeAlD
Nateglinide—CYP2C9—liver—obesity	5.72e-05	0.0048	CbGeAlD
Nateglinide—Palpitations—Topiramate—obesity	5.69e-05	0.0019	CcSEcCtD
Nateglinide—Diarrhoea—Bupropion—obesity	5.64e-05	0.00189	CcSEcCtD
Nateglinide—Nausea—Sibutramine—obesity	5.62e-05	0.00188	CcSEcCtD
Nateglinide—Cough—Topiramate—obesity	5.62e-05	0.00188	CcSEcCtD
Nateglinide—Dizziness—Bupropion—obesity	5.45e-05	0.00183	CcSEcCtD
Nateglinide—Vomiting—Bupropion—obesity	5.24e-05	0.00176	CcSEcCtD
Nateglinide—Rash—Bupropion—obesity	5.2e-05	0.00174	CcSEcCtD
Nateglinide—Dermatitis—Bupropion—obesity	5.2e-05	0.00174	CcSEcCtD
Nateglinide—Hyperhidrosis—Topiramate—obesity	5.08e-05	0.0017	CcSEcCtD
Nateglinide—Nausea—Bupropion—obesity	4.9e-05	0.00164	CcSEcCtD
Nateglinide—CYP3A4—endocrine gland—obesity	4.84e-05	0.00406	CbGeAlD
Nateglinide—CYP2D6—endocrine gland—obesity	4.76e-05	0.00399	CbGeAlD
Nateglinide—Enalapril—ACE—obesity	4.65e-05	0.0337	CrCbGaD
Nateglinide—Dyspepsia—Topiramate—obesity	4.63e-05	0.00155	CcSEcCtD
Nateglinide—Gastrointestinal disorder—Topiramate—obesity	4.54e-05	0.00152	CcSEcCtD
Nateglinide—Fatigue—Topiramate—obesity	4.53e-05	0.00152	CcSEcCtD
Nateglinide—CYP3A4—liver—obesity	4.36e-05	0.00366	CbGeAlD
Nateglinide—Gastrointestinal pain—Topiramate—obesity	4.3e-05	0.00144	CcSEcCtD
Nateglinide—CYP2D6—liver—obesity	4.3e-05	0.0036	CbGeAlD
Nateglinide—Urticaria—Topiramate—obesity	4.17e-05	0.0014	CcSEcCtD
Nateglinide—Abdominal pain—Topiramate—obesity	4.15e-05	0.00139	CcSEcCtD
Nateglinide—Hypersensitivity—Topiramate—obesity	3.87e-05	0.0013	CcSEcCtD
Nateglinide—Asthenia—Topiramate—obesity	3.77e-05	0.00126	CcSEcCtD
Nateglinide—Pruritus—Topiramate—obesity	3.72e-05	0.00124	CcSEcCtD
Nateglinide—Diarrhoea—Topiramate—obesity	3.6e-05	0.0012	CcSEcCtD
Nateglinide—Dizziness—Topiramate—obesity	3.48e-05	0.00116	CcSEcCtD
Nateglinide—Vomiting—Topiramate—obesity	3.34e-05	0.00112	CcSEcCtD
Nateglinide—Rash—Topiramate—obesity	3.31e-05	0.00111	CcSEcCtD
Nateglinide—Dermatitis—Topiramate—obesity	3.31e-05	0.00111	CcSEcCtD
Nateglinide—Nausea—Topiramate—obesity	3.12e-05	0.00104	CcSEcCtD
Nateglinide—Amphetamine—SLC6A4—obesity	2.3e-05	0.0167	CrCbGaD
Nateglinide—Amphetamine—DRD2—obesity	2.29e-05	0.0166	CrCbGaD
Nateglinide—Methamphetamine—SLC6A4—obesity	2.13e-05	0.0154	CrCbGaD
Nateglinide—CYP3A4—Metabolism—FADS1—obesity	8.45e-07	2.36e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HADH—obesity	8.45e-07	2.36e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PCK1—obesity	8.45e-07	2.36e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—obesity	8.39e-07	2.34e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOB—obesity	8.35e-07	2.33e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NCOA1—obesity	8.34e-07	2.33e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CG—obesity	8.34e-07	2.33e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SREBF1—obesity	8.33e-07	2.32e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—obesity	8.28e-07	2.31e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SREBF1—obesity	8.26e-07	2.3e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NOS3—obesity	8.23e-07	2.3e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3R1—obesity	8.23e-07	2.3e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP19A1—obesity	8.22e-07	2.29e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—STK11—obesity	8.22e-07	2.29e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ACP5—obesity	8.22e-07	2.29e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—MYC—obesity	8.17e-07	2.28e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GOT2—obesity	8.1e-07	2.26e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CG—obesity	8.08e-07	2.26e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPARG—obesity	8.05e-07	2.25e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GOT2—obesity	8.03e-07	2.24e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—G6PD—obesity	8.01e-07	2.24e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—LPL—obesity	7.97e-07	2.22e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—POMC—obesity	7.94e-07	2.22e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—FASN—obesity	7.93e-07	2.21e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—obesity	7.92e-07	2.21e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SREBF2—obesity	7.91e-07	2.21e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HK1—obesity	7.91e-07	2.21e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—BCHE—obesity	7.9e-07	2.2e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—INS—obesity	7.89e-07	2.2e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—FASN—obesity	7.86e-07	2.19e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—BCHE—obesity	7.83e-07	2.18e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARG—obesity	7.8e-07	2.18e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GPX1—obesity	7.77e-07	2.17e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—POMC—obesity	7.69e-07	2.15e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—INS—obesity	7.65e-07	2.14e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—COMT—obesity	7.64e-07	2.13e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LPA—obesity	7.64e-07	2.13e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP2E1—obesity	7.62e-07	2.13e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CB—obesity	7.6e-07	2.12e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CD36—obesity	7.57e-07	2.11e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP2E1—obesity	7.55e-07	2.11e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARGC1A—obesity	7.54e-07	2.1e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GNB3—obesity	7.54e-07	2.1e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NQO1—obesity	7.53e-07	2.1e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PTGS2—obesity	7.53e-07	2.1e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PIK3CA—obesity	7.52e-07	2.1e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HMOX1—obesity	7.5e-07	2.09e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LPIN1—obesity	7.48e-07	2.09e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NQO1—obesity	7.47e-07	2.08e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GNAS—obesity	7.34e-07	2.05e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CD—obesity	7.33e-07	2.05e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA5—obesity	7.33e-07	2.04e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—obesity	7.31e-07	2.04e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PIK3CA—obesity	7.29e-07	2.04e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—obesity	7.24e-07	2.02e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—ALB—obesity	7.24e-07	2.02e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GCG—obesity	7.22e-07	2.02e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC2A4—obesity	7.22e-07	2.02e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PIK3CA—obesity	7.19e-07	2.01e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOB—obesity	7.19e-07	2.01e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—MTHFR—obesity	7.17e-07	2e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC2A4—obesity	7.16e-07	2e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GCG—obesity	7.16e-07	2e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYCS—obesity	7.13e-07	1.99e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CD—obesity	7.11e-07	1.98e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYCS—obesity	7.07e-07	1.97e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARA—obesity	7.04e-07	1.96e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—TGFB1—obesity	7.03e-07	1.96e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—ALB—obesity	7.02e-07	1.96e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GGT1—obesity	6.99e-07	1.95e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GOT1—obesity	6.99e-07	1.95e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CLOCK—obesity	6.99e-07	1.95e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC22A1—obesity	6.99e-07	1.95e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GOT1—obesity	6.93e-07	1.93e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GGT1—obesity	6.93e-07	1.93e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NOS3—obesity	6.92e-07	1.93e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3R1—obesity	6.92e-07	1.93e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NCOA1—obesity	6.89e-07	1.92e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—LPL—obesity	6.86e-07	1.92e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NCOA1—obesity	6.83e-07	1.91e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AGT—obesity	6.82e-07	1.9e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SULT2A1—obesity	6.81e-07	1.9e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GLP1R—obesity	6.81e-07	1.9e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—STK11—obesity	6.79e-07	1.89e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP19A1—obesity	6.79e-07	1.89e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—STK11—obesity	6.73e-07	1.88e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP19A1—obesity	6.73e-07	1.88e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NOS3—obesity	6.71e-07	1.87e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3R1—obesity	6.71e-07	1.87e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—DPYD—obesity	6.7e-07	1.87e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GPX1—obesity	6.7e-07	1.87e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOE—obesity	6.68e-07	1.86e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CAV1—obesity	6.62e-07	1.85e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—APOA1—obesity	6.6e-07	1.84e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CD36—obesity	6.52e-07	1.82e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PRKAR2B—obesity	6.45e-07	1.8e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—DCN—obesity	6.4e-07	1.79e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CB—obesity	6.39e-07	1.78e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PTGS2—obesity	6.33e-07	1.77e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—COMT—obesity	6.31e-07	1.76e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—COMT—obesity	6.26e-07	1.75e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CPT1A—obesity	6.23e-07	1.74e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARGC1A—obesity	6.22e-07	1.74e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GNB3—obesity	6.22e-07	1.74e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HMOX1—obesity	6.2e-07	1.73e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CB—obesity	6.19e-07	1.73e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—MTHFR—obesity	6.18e-07	1.72e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARGC1A—obesity	6.17e-07	1.72e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GNB3—obesity	6.17e-07	1.72e-05	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—AKT1—obesity	6.14e-07	1.71e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HMOX1—obesity	6.14e-07	1.71e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PTGS2—obesity	6.14e-07	1.71e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NAMPT—obesity	6.11e-07	1.7e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LIPC—obesity	6.07e-07	1.69e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GCK—obesity	6.07e-07	1.69e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARA—obesity	6.06e-07	1.69e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GNAS—obesity	6.06e-07	1.69e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOC3—obesity	6.03e-07	1.68e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CG—obesity	6.03e-07	1.68e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GNAS—obesity	6.01e-07	1.68e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—PIK3CA—obesity	5.98e-07	1.67e-05	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—AKT1—obesity	5.96e-07	1.66e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOB—obesity	5.93e-07	1.66e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOB—obesity	5.88e-07	1.64e-05	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—AKT1—obesity	5.87e-07	1.64e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AGT—obesity	5.87e-07	1.64e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CETP—obesity	5.86e-07	1.63e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARG—obesity	5.82e-07	1.62e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SDC1—obesity	5.79e-07	1.62e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOE—obesity	5.75e-07	1.61e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—POMC—obesity	5.74e-07	1.6e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—INS—obesity	5.71e-07	1.59e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CAV1—obesity	5.7e-07	1.59e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKR1C3—obesity	5.7e-07	1.59e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—APOA1—obesity	5.69e-07	1.59e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—LPL—obesity	5.67e-07	1.58e-05	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—AKT1—obesity	5.66e-07	1.58e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—LPL—obesity	5.62e-07	1.57e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SCARB1—obesity	5.61e-07	1.57e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GPX1—obesity	5.53e-07	1.54e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GPX1—obesity	5.48e-07	1.53e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.45e-07	1.52e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SREBF1—obesity	5.45e-07	1.52e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—PIK3CA—obesity	5.39e-07	1.5e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CD36—obesity	5.38e-07	1.5e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CD36—obesity	5.34e-07	1.49e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CD—obesity	5.3e-07	1.48e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GOT2—obesity	5.3e-07	1.48e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—ALB—obesity	5.23e-07	1.46e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CG—obesity	5.19e-07	1.45e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—FASN—obesity	5.18e-07	1.45e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—BCHE—obesity	5.16e-07	1.44e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—MTHFR—obesity	5.1e-07	1.42e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—MTHFR—obesity	5.06e-07	1.41e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARG—obesity	5.01e-07	1.4e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARA—obesity	5.01e-07	1.4e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3R1—obesity	5e-07	1.4e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NOS3—obesity	5e-07	1.4e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP2E1—obesity	4.98e-07	1.39e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARA—obesity	4.96e-07	1.38e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—POMC—obesity	4.94e-07	1.38e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NQO1—obesity	4.92e-07	1.37e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—INS—obesity	4.91e-07	1.37e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT1—obesity	4.89e-07	1.36e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AGT—obesity	4.85e-07	1.35e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AGT—obesity	4.81e-07	1.34e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOE—obesity	4.75e-07	1.33e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GCG—obesity	4.72e-07	1.32e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC2A4—obesity	4.72e-07	1.32e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOE—obesity	4.71e-07	1.31e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CAV1—obesity	4.71e-07	1.31e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—APOA1—obesity	4.7e-07	1.31e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CAV1—obesity	4.67e-07	1.3e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYCS—obesity	4.66e-07	1.3e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—APOA1—obesity	4.65e-07	1.3e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PIK3CA—obesity	4.63e-07	1.29e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CB—obesity	4.62e-07	1.29e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PTGS2—obesity	4.58e-07	1.28e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GGT1—obesity	4.57e-07	1.28e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GOT1—obesity	4.57e-07	1.28e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CD—obesity	4.56e-07	1.27e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NCOA1—obesity	4.5e-07	1.26e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—obesity	4.46e-07	1.24e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—STK11—obesity	4.44e-07	1.24e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP19A1—obesity	4.44e-07	1.24e-05	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—AKT1—obesity	4.4e-07	1.23e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3R1—obesity	4.31e-07	1.2e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NOS3—obesity	4.31e-07	1.2e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CG—obesity	4.29e-07	1.2e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CG—obesity	4.25e-07	1.19e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARG—obesity	4.14e-07	1.15e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—COMT—obesity	4.13e-07	1.15e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARG—obesity	4.1e-07	1.14e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—POMC—obesity	4.08e-07	1.14e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARGC1A—obesity	4.07e-07	1.14e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GNB3—obesity	4.07e-07	1.14e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—INS—obesity	4.06e-07	1.13e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HMOX1—obesity	4.05e-07	1.13e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—POMC—obesity	4.05e-07	1.13e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—INS—obesity	4.02e-07	1.12e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CB—obesity	3.98e-07	1.11e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GNAS—obesity	3.96e-07	1.11e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PTGS2—obesity	3.94e-07	1.1e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PIK3CA—obesity	3.9e-07	1.09e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOB—obesity	3.88e-07	1.08e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKT1—obesity	3.78e-07	1.06e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PIK3CA—obesity	3.78e-07	1.05e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CD—obesity	3.77e-07	1.05e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CD—obesity	3.74e-07	1.04e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—ALB—obesity	3.72e-07	1.04e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LPL—obesity	3.7e-07	1.03e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—ALB—obesity	3.69e-07	1.03e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GPX1—obesity	3.61e-07	1.01e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NOS3—obesity	3.56e-07	9.93e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3R1—obesity	3.56e-07	9.93e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3R1—obesity	3.53e-07	9.84e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NOS3—obesity	3.53e-07	9.84e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CD36—obesity	3.52e-07	9.82e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MTHFR—obesity	3.34e-07	9.31e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CB—obesity	3.28e-07	9.17e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARA—obesity	3.27e-07	9.13e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CB—obesity	3.26e-07	9.09e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PTGS2—obesity	3.25e-07	9.08e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PTGS2—obesity	3.23e-07	9e-06	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKT1—obesity	3.18e-07	8.88e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AGT—obesity	3.17e-07	8.84e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOE—obesity	3.11e-07	8.67e-06	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKT1—obesity	3.08e-07	8.61e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CAV1—obesity	3.08e-07	8.59e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—APOA1—obesity	3.07e-07	8.57e-06	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PIK3CA—obesity	2.82e-07	7.86e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CG—obesity	2.8e-07	7.82e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARG—obesity	2.7e-07	7.55e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—POMC—obesity	2.67e-07	7.44e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—INS—obesity	2.65e-07	7.4e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CD—obesity	2.46e-07	6.88e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ALB—obesity	2.43e-07	6.79e-06	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PIK3CA—obesity	2.43e-07	6.77e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3R1—obesity	2.33e-07	6.49e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NOS3—obesity	2.33e-07	6.49e-06	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKT1—obesity	2.3e-07	6.42e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CB—obesity	2.15e-07	5.99e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PTGS2—obesity	2.13e-07	5.94e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PIK3CA—obesity	2e-07	5.59e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PIK3CA—obesity	1.98e-07	5.54e-06	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKT1—obesity	1.98e-07	5.53e-06	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKT1—obesity	1.64e-07	4.56e-06	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKT1—obesity	1.62e-07	4.53e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PIK3CA—obesity	1.31e-07	3.65e-06	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKT1—obesity	1.07e-07	2.98e-06	CbGpPWpGaD
